Metraipolis › archive › dc_91ff7a3ebbf0

NETest2.0® Demonstrates Superior Monitoring Performance Compared with Chromogranin A in Neuroendocrine Tumor Surveillance — Europe PMC PMID:42512273

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42512273
DOI
10.3390/cancers18142206
License (as archived)
solo-consultazione
Archived
2026-10-18T09:38:01.632Z
SHA-256 of the archived text
cde9136b39103fd19af79212369fc4cf2b91100bac9bf9277a3bacc53f31e260
Stable URL of this page
https://metraipolis.com/documento/dc_91ff7a3ebbf0

How to cite

NETest2.0® Demonstrates Superior Monitoring Performance Compared with Chromogranin A in Neuroendocrine Tumor Surveillance — Europe PMC PMID:42512273 — Europe PMC (en), https://europepmc.org/article/MED/42512273 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_91ff7a3ebbf0 (Metraipolis archive dc_91ff7a3ebbf0, sha256 cde9136b39103fd19af79212369fc4cf2b91100bac9bf9277a3bacc53f31e260)
BibTeX
@misc{dc91ff7a3ebbf0,
  title = {NETest2.0® Demonstrates Superior Monitoring Performance Compared with Chromogranin A in Neuroendocrine Tumor Surveillance — Europe PMC PMID:42512273},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512273},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_91ff7a3ebbf0; sha256 cde9136b39103fd19af79212369fc4cf2b91100bac9bf9277a3bacc53f31e260},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512273. Agents can read the archived copy with the MCP tool read_document.